Gene Therapy Product Cyl-02 = Plasmid Dna Pre-Complexed To Linear Polyethylenimine Encoding Sst2 + Dck::Umk Genes
Pancreatic Adenocarcinoma
University Hospital, Toulousegene_therapyPhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 73/ 100
Competitive context
190 Active assets in the Pancreatic Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Jonsson Comprehensive Cancer Center | Phase 4 | BBB |
Docetaxel Bristol-Myers Squibb | Phase 2 | BBB |
Irinotecan Jonsson Comprehensive Cancer Center | Phase 3 | BB |
Eloxatin Jonsson Comprehensive Cancer Center | Phase 4 | BB |
Irinotecan Ipsen | Phase 3 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →